IHCU.L vs. SBIO.L
IHCU.L (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) and SBIO.L (Invesco Nasdaq Biotech UCITS ETF) are both Health & Biotech Equities funds - IHCU.L tracks the iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) while SBIO.L tracks the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 10 years, IHCU.L returned 9.36%/yr vs 8.67%/yr for SBIO.L. A 0.66 correlation means they provide meaningful diversification when combined. IHCU.L charges 0.15%/yr vs 0.40%/yr for SBIO.L.
Performance
IHCU.L vs. SBIO.L - Performance Comparison
Loading charts...
Different Trading Currencies
IHCU.L is traded in GBp, while SBIO.L is traded in USD. To make them comparable, the SBIO.L values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, IHCU.L achieves a 3.10% return, which is significantly lower than SBIO.L's 14.29% return. Over the past 10 years, IHCU.L has outperformed SBIO.L with an annualized return of 9.36%, while SBIO.L has yielded a comparatively lower 8.67% annualized return.
IHCU.L
- 1D
- 0.45%
- 1M
- 4.09%
- 6M
- 1.95%
- YTD
- 3.10%
- 1Y
- 20.87%
- 3Y*
- 7.15%
- 5Y*
- 6.27%
- 10Y*
- 9.36%
SBIO.L
- 1D
- -0.60%
- 1M
- 8.23%
- 6M
- 12.13%
- YTD
- 14.29%
- 1Y
- 47.96%
- 3Y*
- 16.16%
- 5Y*
- 6.16%
- 10Y*
- 8.67%
IHCU.L vs. SBIO.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IHCU.L iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) | 3.10% | 6.77% | 3.96% | -3.89% | 8.99% | 29.15% | 8.09% | 16.89% | 10.43% | 11.31% |
SBIO.L Invesco Nasdaq Biotech UCITS ETF | 14.29% | 23.42% | -0.28% | 0.84% | -1.37% | 0.45% | 23.61% | 20.76% | -6.08% | 10.95% |
Correlation
The correlation between IHCU.L and SBIO.L is 0.64, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.64 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.56 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.58 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.65 |
Correlation (All Time) Calculated using the full available price history since Nov 20, 2015 | 0.66 |
The correlation between IHCU.L and SBIO.L shifts across timeframes, from 0.56 (3 years) to 0.66 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IHCU.L vs. SBIO.L — Risk / Return Rank
IHCU.L
SBIO.L
IHCU.L vs. SBIO.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) (IHCU.L) and Invesco Nasdaq Biotech UCITS ETF (SBIO.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IHCU.L | SBIO.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.99 | ||
| Sortino ratioReturn per unit of downside risk | -1.14 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.38 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 1.79 | 6.71 | -4.92 |
| Martin ratioReturn relative to average drawdown | 4.47 | 18.88 | -14.41 |
Loading charts...
Drawdowns
IHCU.L vs. SBIO.L - Drawdown Comparison
The maximum IHCU.L drawdown since its inception was -38.44%, which is greater than SBIO.L's maximum drawdown of -34.90%. Use the drawdown chart below to compare losses from any high point for IHCU.L and SBIO.L.
Loading charts...
Drawdown Indicators
| IHCU.L | SBIO.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.44% | -34.90% | -3.54% |
Max Drawdown (1Y)Largest decline over 1 year | -11.54% | -7.11% | -4.43% |
Max Drawdown (3Y)Largest decline over 3 years | -23.98% | -26.49% | +2.51% |
Max Drawdown (5Y)Largest decline over 5 years | -23.98% | -30.92% | +6.94% |
Max Drawdown (10Y)Largest decline over 10 years | -23.98% | -30.92% | +6.94% |
Current DrawdownCurrent decline from peak | -4.34% | -5.36% | +1.02% |
Average DrawdownAverage peak-to-trough decline | -9.78% | -10.55% | +0.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.63% | 2.53% | +2.10% |
Volatility
IHCU.L vs. SBIO.L - Volatility Comparison
The current volatility for iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) (IHCU.L) is 5.45%, while Invesco Nasdaq Biotech UCITS ETF (SBIO.L) has a volatility of 6.82%. This indicates that IHCU.L experiences smaller price fluctuations and is considered to be less risky than SBIO.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IHCU.L | SBIO.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.45% | 6.82% | -1.37% |
Volatility (6M)Calculated over the trailing 6-month period | 11.14% | 15.17% | -4.03% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.18% | 20.38% | -5.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.31% | 20.90% | -0.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.55% | 22.37% | -3.82% |
IHCU.L vs. SBIO.L - Expense Ratio Comparison
IHCU.L has a 0.15% expense ratio, which is lower than SBIO.L's 0.40% expense ratio.
Dividends
IHCU.L vs. SBIO.L - Dividend Comparison
Neither IHCU.L nor SBIO.L has paid dividends to shareholders.
Frequently Asked Questions
IHCU.L and SBIO.L have a correlation of 0.64, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IHCU.L is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IHCU.L is cheaper with a 0.15% expense ratio, compared with 0.40% for SBIO.L.
IHCU.L tracks iShares S&P 500 Health Care Sector UCITS ETF USD (Acc), while SBIO.L tracks NASDAQ Biotechnology TR USD. They also come from different issuers: iShares and Invesco. Their fees differ too: 0.15% for IHCU.L and 0.40% for SBIO.L.
Find the right allocation for IHCU.L and SBIO.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer